Zakrzewski Joseph S 4
4 · Cyteir Therapeutics, Inc. · Filed Feb 8, 2024
Insider Transaction Report
Form 4
Zakrzewski Joseph S
Director
Transactions
- Exercise/Conversion
Common Stock
2024-02-06$1.69/sh+14,150$23,914→ 227,439 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-06−14,150→ 0 totalExercise: $1.69From: 2024-02-03Exp: 2033-02-03→ Common Stock (14,150 underlying)
Holdings
- 149,051(indirect: See Footnote)
Common Stock
Footnotes (1)
- [F1]Shares held by Z3 Trust, of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of his pecuniary interest therein.